Trials in Philadelphia, Pennsylvania
Here are the top 10 medical studies for alzheimer's disease in Philadelphia, Pennsylvania
Popular Filters
Phase 3 Trials
Glucagon-like peptide-1 (GLP-1) receptor agonist
Semaglutide for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Jenkintown, Pennsylvania
This trial is testing whether semaglutide has a positive effect on early Alzheimer's disease by comparing it to a placebo. There will be 17 clinic visits and 1 phone call with the study doctor, and various tests and scans will be performed. The study will last for up to 173 weeks.
Behavioural Intervention
KarXT for Alzheimer's-Associated Psychosis
Recruiting1 awardPhase 3
Allentown, Pennsylvania
This trial is testing KarXT, a medication, to see if it can prevent psychotic symptoms from returning in people with Alzheimer's Disease. It works by balancing brain chemicals that cause hallucinations and delusions. KarXT has shown positive results in reducing symptoms of schizophrenia.
Monoclonal Antibodies
Donanemab for Alzheimer's Disease
Recruiting1 awardPhase 3
Springfield, New Jersey
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Trials With No Placebo
Behavioral Intervention
Video Program for Alzheimer's Disease
Recruiting1 award2 criteria
New York, New York
This trial will test a new video program called Resilient Together for Dementia (RT-D) to see if it can help prevent emotional distress and improve quality of life for people with Alzheimer's disease
Behavioral Nudge for Genetic Predisposition
Recruiting1 award2 criteria
Philadelphia, Pennsylvania
This trial aims to find new ways to deliver genetic testing results that can change medical management beyond traditional genetic counseling visits. The study will use non-geneticist clinicians and patient nudges in a randomized clinical
Behavioral Intervention
Pharmacist-led Deprescribing for Alzheimer's Disease
Recruiting1 award
Baltimore, Maryland
This trial aims to test a pharmacist-led program to help people with dementia and their care partners reduce the number of medications they are taking. The program includes an educational brochure, a telehealth visit with a
Behavioural Intervention
Sensory Stimulation for Alzheimer's Disease
Recruiting1 award
Jenkintown, Pennsylvania
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this
Ultrasound Therapy
ExAblate BBB Disruption for Alzheimer's Disease
Recruiting1 award5 criteria
New York, New York
This trial is testing a device that uses ultrasound waves to temporarily open the brain's protective barrier in patients with Alzheimer's Disease. The goal is to see if this can help medications reach the brain better. Focused ultrasound with microbubbles has been studied recently and shows promise for opening the brain's protective barrier in Alzheimer's disease treatment.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.